These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 37905425)

  • 1. PrEP retention predictors among key populations in urban areas of Zimbabwe - a machine learning approach.
    Bero B; Zidana C; Showa SP
    Afr J AIDS Res; 2023 Nov; 22(3):157-164. PubMed ID: 37905425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engagement in the pre-exposure prophylaxis (PrEP) cascade among a respondent-driven sample of sexually active men who have sex with men and transgender women during early PrEP implementation in Zimbabwe.
    Parmley LE; Harris TG; Chingombe I; Mapingure M; Mugurungi O; Rogers JH; Gozhora P; Wu Y; Samba C; Musuka G; Hakim AJ
    J Int AIDS Soc; 2022 Feb; 25(2):e25873. PubMed ID: 35148029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased condom use among key populations using oral PrEP in Kenya: results from large scale programmatic surveillance.
    Manguro GO; Musau AM; Were DK; Tengah S; Wakhutu B; Reed J; Plotkin M; Luchters S; Gichangi P; Temmerman M
    BMC Public Health; 2022 Feb; 22(1):304. PubMed ID: 35164707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: Results from a prospective observational demonstration project.
    Eakle R; Gomez GB; Naicker N; Bothma R; Mbogua J; Cabrera Escobar MA; Saayman E; Moorhouse M; Venter WDF; Rees H;
    PLoS Med; 2017 Nov; 14(11):e1002444. PubMed ID: 29161256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barriers and facilitators to pre-exposure prophylaxis uptake among male sex workers in Mexico: an application of the RE-AIM framework.
    Kadiamada-Ibarra H; Hawley NL; Sosa-Rubí SG; Wilson-Barthes M; Franco RR; Galárraga O
    BMC Public Health; 2021 Nov; 21(1):2174. PubMed ID: 34837988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors motivating female sex workers to initiate pre- exposure prophylaxis for HIV prevention in Zimbabwe.
    Nhamo D; Duma SE; Ojewole EB; Chibanda D; Cowan FM
    PLoS One; 2022; 17(7):e0264470. PubMed ID: 35797351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How Can Programs Better Support Female Sex Workers to Avoid HIV Infection in Zimbabwe? A Prevention Cascade Analysis.
    Fearon E; Phillips A; Mtetwa S; Chabata ST; Mushati P; Cambiano V; Busza J; Napierala S; Hensen B; Baral S; Weir SS; Rice B; Cowan FM; Hargreaves JR
    J Acquir Immune Defic Syndr; 2019 May; 81(1):24-35. PubMed ID: 30964804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uptake and retention on HIV pre-exposure prophylaxis among key and priority populations in South-Central Uganda.
    Kagaayi J; Batte J; Nakawooya H; Kigozi B; Nakigozi G; Strömdahl S; Ekström AM; Chang LW; Gray R; Reynolds SJ; Komaketch P; Alamo S; Serwadda D
    J Int AIDS Soc; 2020 Aug; 23(8):e25588. PubMed ID: 32785976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV Pre-exposure Prophylaxis Uptake and Continuation Among Key Populations in Cameroon: Lessons Learned From the CHAMP Program.
    Ndenkeh JJN; Bowring AL; Njindam IM; Folem RD; Fako GCH; Ngueguim FG; Gayou OL; Lepawa K; Minka CM; Batoum CM; Georges S; Temgoua E; Nzima V; Kob DA; Akiy ZZ; Philbrick W; Levitt D; Curry D; Baral S
    J Acquir Immune Defic Syndr; 2022 Sep; 91(1):39-46. PubMed ID: 35536113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acceptability of pre-exposure prophylaxis for HIV prevention: facilitators, barriers and impact on sexual risk behaviors among men who have sex with men in Benin.
    Ahouada C; Diabaté S; Mondor M; Hessou S; Guédou FA; Béhanzin L; Batona G; Gning NN; Zannou DM; Alary M
    BMC Public Health; 2020 Aug; 20(1):1267. PubMed ID: 32819335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demographic and behavioral characteristics of urban and non-urban PrEP-using MSM in the South.
    Jones J; Pampati S; Emrick K; Siegler AJ
    AIDS Care; 2022 Nov; 34(11):1461-1464. PubMed ID: 35676749
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Ben Moussa A; Belhiba O; Sodqi M; Hajouji FZ; Salah NEI; Sakhri N; Alami K; Omari BE; Ouarsas L; Karkouri M
    AIDS Care; 2024 Apr; 36(4):508-516. PubMed ID: 37795685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of self-selection based on HIV risk on the cost-effectiveness of preexposure prophylaxis in South Africa.
    Jamieson L; Gomez GB; Rebe K; Brown B; Subedar H; Jenkins S; Shoko N; Bekker LG; Johnson LF; Meyer-Rath G
    AIDS; 2020 May; 34(6):883-891. PubMed ID: 32004205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daily and event-driven pre-exposure prophylaxis for men who have sex with men in Belgium: results of a prospective cohort measuring adherence, sexual behaviour and STI incidence.
    Vuylsteke B; Reyniers T; De Baetselier I; Nöstlinger C; Crucitti T; Buyze J; Kenyon C; Wouters K; Laga M
    J Int AIDS Soc; 2019 Oct; 22(10):e25407. PubMed ID: 31663257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-retroviral Therapy Based HIV Prevention Among a Sample of Men Who Have Sex with Men in Cape Town, South Africa: Use of Post-exposure Prophylaxis and Knowledge on Pre-exposure Prophylaxis.
    Hugo JM; Stall RD; Rebe K; Egan JE; De Swardt G; Struthers H; McIntyre JA
    AIDS Behav; 2016 Dec; 20(Suppl 3):357-364. PubMed ID: 27631366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Policymakers' and healthcare providers' perspectives on the introduction of oral pre-exposure prophylaxis for key populations in Ghana.
    Nagai H; Adiibokah E; Tagoe H; Tun W; Pilgrim NA; Ankomah A; Rahman YAA; Addo SA; Atuahene SK; Essandoh E; Maher S; Kowalski M
    BMC Public Health; 2023 Jun; 23(1):1065. PubMed ID: 37277772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protocol for a multicenter, real-world study of HIV pre-exposure prophylaxis among men who have sex with men in China (CROPrEP).
    Wang H; Zhang Y; Mei Z; Jia Y; Leuba SI; Zhang J; Chu Z; Ding H; Jiang Y; Geng W; Shang H; Xu J
    BMC Infect Dis; 2019 Aug; 19(1):721. PubMed ID: 31416439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PrEP for key populations: results from the first PrEP demonstration project in the Democratic Republic of the Congo.
    Franks J; Teasdale C; Olsen H; Wang C; Mushimebele N; Tenda Mazala R; Tchissambou T; Malele Bazola F; Bingham T; Djomand G; Mukinda E; Ewetola R; Abrams E; Reidy W
    AIDS Care; 2022 Mar; 34(3):359-362. PubMed ID: 34495772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demonstration project of oral TDF-containing PrEP, administered, once-daily orally to men having sex with men (MSM) and transgender women (TGW) in India: Study protocol.
    Sahay S; Bangar S; Chandhiok N
    PLoS One; 2023; 18(6):e0287454. PubMed ID: 37352188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Travestis, transgender women and young MSM are at high risk for PrEP early loss to follow-up in Rio de Janeiro, Brazil.
    Echeverría-Guevara A; Coelho LE; Veloso VG; Pimenta MC; Hoagland B; Moreira RI; Leite I; Jalil EM; Cardoso SW; Torres TS; Grinsztejn B
    Braz J Infect Dis; 2023; 27(1):102733. PubMed ID: 36586721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.